TDAG51 in the anterior temporal neocortex of patients with intractable epilepsy

Neuroscience Letters

Volumn 425, Issue 1, 2007, Pages 53-58

  Xi, Zhi qin ^a   Wang, Lin yuan ^b   Sun, Ji jun ^a   Liu, Xian zeng ^c   Zhu, Xi ^a   Xiao, Fei ^a   Guan, Li feng ^a   Li, Jin mei ^a   Wang, Liang ^a   Wang, Xue feng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Epilepsy; Patients; T cell death associated gene 51

Indexed keywords

PROTEIN; PROTEIN TDAG51; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRAIN DECOMPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPTOGENESIS; FEMALE; GENE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HYPERTENSION; INTRACTABLE EPILEPSY; MALE; NEOCORTEX; NERVE CELL; NEUROCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TDAG51 GENE; WESTERN BLOTTING;

ADOLESCENT; ADULT; CHILD; EPILEPSY; FEMALE; HUMANS; MALE; TEMPORAL LOBE; TRANSCRIPTION FACTORS;

EID: 34548625527     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.08.016     Document Type: Article

References (40)

1. Bernard C., Anderson A., Becker A., Poolos N.P., Beck H., and Johnston D. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 305 5683 (2004) 532-535
2. Chengyun D., Guoming L., Elia M., Catania M.V., and Qunyuan X. Expression of multidrug resistance type 1 gene (MDR1) P-glycoprotein in intractable epilepsy with different aetiologies: a double-labelling and electron microscopy study. Neurol. Sci. 27 (2006) 245-251
3. Crews F.T., McElhaney R., Freund G., Ballinger Jr. W.E., and Raizada M.K. Insulin-like growth factor I receptor binding in brains of Alzheimer's and alcoholic patients. J. Neurochem. 58 (1992) 1205-1210
4. Dawodu S., and Thom M. Quantitative neuropathology of the entorhinal cortex region in patients with hippocampal sclerosis and temporal lobe epilepsy. Epilepsia 46 (2005) 23-30
5. Diaz-Arrastia R. Homocysteine and neurologic disease. Arch. Neurol. 57 (2000) 1422-1427
6. Ekdahl C.T., Zhu C., Bonde S., Bahr B.A., Blomgren K., and Lindvall O. Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival. Neurobiol. Dis. 14 (2003) 513-523
7. Epsztein J., Milh M., Bihi R.I., Jorquera I., Ben-Ari Y., Represa A., and Crepel V. Ongoing epileptiform activity in the post-ischemic hippocampus is associated with a permanent shift of the excitatory-inhibitory synaptic balance in CA3 pyramidal neurons. J. Neurosci. 26 (2006) 7082-7092
8. Fujikawa D.G. Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav. Suppl. 3 (2005) 3-11
9. Henshall D.C., Bonislawski D.P., Skradski S.L., Araki T., Lan J.Q., Schindler C.K., Meller R., and Simon R.P. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ. 8 (2001) 1169-1181
10. Henshall D.C., Clark R.S., Adelson P.D., Chen M., Watkins S.C., and Simon R.P. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 55 (2000) 250-257
11. Hinz T., Flindt S., Marx A., Janssen O., and Kabelitz D. Inhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product. Cell Signal. 13 (2001) 345-352
12. Hossain G.S., van Thienen J.V., Werstuck G.H., Zhou J., Sood S.K., Dickhout J.G., de Koning A.B., Tang D., Wu D., Falk E., Poddar R., Jacobsen D.W., Zhang K., Kaufman R.J., and Austin R.C. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia. J. Biol. Chem. 278 (2003) 30317-30327
13. Huemer M., Ausserer B., Graninger G., Hubmann M., Huemer C., Schlachter K., Tscharre A., Ulmer H., and Simma B. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia 46 (2005) 1677-1683
14. Jeon S.H., Kim Y.S., Bae C.D., and Park J.B. Activation of JNK and p38 in rat hippocampus after kainic acid induced seizure. Exp. Mol. Med. 32 (2000) 227-330
15. Jiang W., Van Cleemput J., Sheerin A.H., Ji S.P., Zhang Y., Saucier D.M., Corcoran M.E., and Zhang X. Involvement of extracellular regulated kinase and p38 kinase in hippocampal seizure tolerance. J. Neurosci. Res. 81 (2005) 581-588
16. Kwan P., and Brodie M.J. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 46 (2005) 224-235
17. Larner S.F., McKinsey D.M., Hayes R.L., and Wang K.K.W. Caspase 7: increased expression and activation after traumatic brain injury in rats. J. Neurochem. 94 (2005) 97-108
18. Lau A., Arundine M., Sun H.S., Jones M., and Tymianski M. Inhibition of caspase-mediated apoptosis by peroxynitrite in traumatic brain injury. J. Neurosci. 26 (2006) 11540-11553
19. Li T., Fan Y., Luo Y., Xiao B., and Lu C. In vivo delivery of a XIAP (BIR3-RING) fusion protein containing the protein transduction domain protects against neuronal death induced by seizures. Exp. Neurol. 197 (2006) 301-308
20. Li J.M., Wang X.F., Xi Z.Q., Gong Y., Liu F.Y., Sun J.J., Wu Y., Luan G.M., Wang Y.P., Li Y.L., Zhang J.G., Lu Y., and Li H.W. Decreased expression of thyroid receptor-associated protein 220 in temporal lobe tissue of patients with refractory epilepsy. Biochem. Biophys. Res. Commun. 348 (2006) 1389-1397
21. McNamara R.K., and Lenox R.H. Differential regulation of primary protein kinase C substrate (MARCKS, MLP, GAP-43, RC3) mRNAs in the hippocampus during kainic acid-induced seizures and synaptic reorganization. J. Neurosci. Res. 62 (2000) 416-426
22. Mielke K., Brecht S., Dorst A., and Herdegen T. Activity and expression of JNK1, p38 and ERK kinases, c-Jun N-terminal phosphorylation, and c-jun promoter binding in the adult rat brain following kainate-induced seizures. Neuroscience 91 (1999) 471-483
23. Mizrahi E.M., Kellaway P., Grossman R.G., Rutecki P.A., Armstrong D., Rettig G., and Loewen S. Anterior temporal lobectomy and medically refractory temporal lobe epilepsy of childhood. Epilepsia 31 (1990) 302-312
24. Narkilahti S., Nissinen J., and Pitkanen A. Administration of caspase 3 inhibitor during and after status epilepticus in rat: effect on neuronal damage and epileptogenesis. Neuropharmacology 44 (2003) 1068-1088
25. Neef R., Kuske M.A., Prols E., and Johnson J.P. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res. 62 (2002) 5920-5929
26. Oberg H.H., Sipos B., Kalthoff H., Janssen O., and Kabelitz D. Regulation of T-cell death-associated gene 51 (TDAG51) expression in human T-cells. Cell Death Differ. 11 (2004) 674-684
27. Özbas-Gerçeker F., Gorter J.A., Redeker S., Ramkema M., van der Valk P., Baayen J.C., Ozguc M., Saygi S., Soylemezoglu F., Akalin N., Troost D., and Aronica E. Neurotrophin receptor immunoreactivity in the hippocampus of patients with mesial temporal lobe epilepsy. Neuropathol. Appl. Neurobiol. 30 (2004) 651-654
28. Park C.G., Lee S.Y., Kandala G., and Choi Y. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity 4 (1996) 583-591
29. Rambeck B., Jurgens U.H., May T.W., Pannek H.W., Behne F., Ebner A., Gorji A., Straub H., Speckmann E.J., Pohlmann-Eden B., and Loscher W. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 47 (2006) 681-694
30. Rho J., Gong S., Kim N., and Choi Y. TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo. Mol. Cell Biol. 21 (2001) 8365-8370
31. Riikonen R., Somer M., and Turpeinen U. Low insulin-like growth factor (IGF-1) in the cerebrospinal fluid of children with progressive encephalopathy, hypsarrhythmia, and optic atrophy (PEHO) syndrome and cerebellar degeneration. Epilepsia 40 (1999) 1642-1648
32. Sen A., Thom M., Martinian L., Jacobs T., Nikolic M., and Sisodiya S.M. Deregulation of cdk5 in Hippocampal sclerosis. J. Neuropathol. Exp. Neurol. 65 (2006) 55-66
33. Sisodiya S.M., Martinian L., Scheffer G.L., van der Valk P., Cross J.H., Scheper R.J., Harding B.N., and Thom M. Major vault protein, a marker of drug resistance,is upregulated in refractory epilepsy. Epilepsia (2003) 1388-1396
34. Tan Z., Levid J., and Schreiber S.S. Increased expression of Fas (CD95/APO-1) in adult rat brain after kainate-induced seizures. Neuroreport 12 (2001) 1979-1982
35. Tang F.R., Lee W.L., Gao H., Chen Y., Loh Y.T., and Chia S.C. Expression of different isoforms of protein kinase C in the rat hippocampus after pilocarpine-induced status epilepticus with special reference to CA1 area and the dentate gyrus. Hippocampus 14 (2004) 87-98
36. Toyoshima Y., Karas M., Yakar S., Dupont J., Lee H., and LeRoith D. TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival. J. Biol. Chem. 279 (2004) 25898-25904
37. Wang R., Zhang L., Yin D., Mufson R.A., and Shi Y. Protein kinase C regulates Fas (CD95/APO-1) expression. J. Immunol. 161 (1998) 2201-2207
38. Wu G., Lu Z.H., Wang J., Wang Y., Xie X., Meyenhofer M.F., and Ledeen R.W. Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. J. Neurosci. 25 (2005) 11014-110422
39. Yamamoto A., Murphy N., Schindler C.K., So N.K., Stohr S., Taki W., Prehn J.H., and Henshall D.C. Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 65 (2006) 217-225
40. Zucchini S., Barbieri M., and Simonato M. Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the fibroblast growth factor-2 system. Epilepsia 46 Suppl 5 (2005) 52-58